received captopril (75 mg/day) and placebo. Laboratory measurements, including measurements of serum potassium and serum creatinine, were performed daily during the study period. Study medication ...

Objective: To verify the feasibility, tolerability and efficacy of the combination of captopril (75 mg/day) and candesartan (8 mg/day) in early postinfarction phases of not thrombolysed and ...

Generally safer than captopril and enalipril, quinapril is one of the most commonly prescribed ACE inhibitors. It also helps ...